GRNA
Closed
Greenlight Biosciences Holdings Pbc
0.2995
0.0000 (0.00%)
Last Update: 27 Jul 2023 16:30:00
Yesterday: 0.2995
Day's Range: 0.2995 - 0.2995
Send
sign up or login to leave a comment!
When Written:
0.4633
Greenlight Biosciences Holdings PBC is a biotechnology company that specializes in RNA-based solutions for agriculture, healthcare, and biodefense. The company was founded in 2008 and is headquartered in Medford, Massachusetts.
Greenlight Biosciences utilizes a proprietary RNA production platform to develop RNA-based products that can be used for crop protection, plant health, and agricultural sustainability. The company also develops RNA-based vaccines and therapeutics for human and animal health, including COVID-19 vaccines.
In addition to its RNA-based solutions, Greenlight Biosciences also offers a suite of analytical services and custom RNA production services to support research and development in the life sciences.
The company has raised over $300 million in funding from investors, including Morningside Ventures, S2G Ventures, and Continental Grain Company.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Greenlight Biosciences utilizes a proprietary RNA production platform to develop RNA-based products that can be used for crop protection, plant health, and agricultural sustainability. The company also develops RNA-based vaccines and therapeutics for human and animal health, including COVID-19 vaccines.
In addition to its RNA-based solutions, Greenlight Biosciences also offers a suite of analytical services and custom RNA production services to support research and development in the life sciences.
The company has raised over $300 million in funding from investors, including Morningside Ventures, S2G Ventures, and Continental Grain Company.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








